Jeffrey A. Graves

Jeffrey A. Graves (chief executive) discloses dealings in 2 companies, chiefly 3D Systems Corp and Integra Lifesciences Holdings Corp. We count 39 filings; the first trade dates from 19 May 2021 and the latest from 17 September 2026.

Both buying and selling appear: 7 purchases worth €783k, against 3 sales worth €1.0M. On balance, insiders were net sellers of €224k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 29 share grants. So far in 2026, the count stands at no purchases and 2 sales.

The median purchase comes to €93k. None of the 7 purchases we analysed coincided with buying by another insider of the same company within 30 days.

Most recently, on 18 September 2026, the filings show an open-market sale worth €132k in 3D Systems Corp. The latest purchase dates back some time: it was published 346 days ago, on 6 November 2025. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.